Treating T2DM and obesity with bariatric surgery and GLP1 agents

被引：0
|
作者：
Clifford J. Bailey
机构：
[1] Aston University,Life and Health Sciences
来源：
Nature Reviews Endocrinology | 2019年 / 15卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Bariatric surgery often produces remission of hyperglycaemia in patients with coexistent obesity and type 2 diabetes mellitus, but the hyperglycaemia is prone to return years later. A prospective study demonstrates that therapy with a glucagon-like peptide 1 receptor agonist can reinstate normal glycaemic control in many of these patients.
引用
收藏
页码：504 / 506
页数：2
相关论文
共 50 条
  • [41] Gut microbial metabolites in obesity, NAFLD and T2DM
    Canfora, Emanuel E.
    Meex, Ruth C. R.
    Venema, Koen
    Blaak, Ellen E.
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (05) : 261 - 273
  • [42] Efficacy and Safety of Naltrexone/Bupropion as Add-On to Incretin Agents in Patients with Obesity and T2DM
    Wharton, Sean
    Yin, Peter
    Camacho, Fernando
    Burrows, Melonie
    Blavignac, Jessica
    Barakat, Maxime
    DIABETES, 2020, 69
  • [43] Treating T2DM by ensuring insulin access is a global challenge
    Horlyck-Romanovsky, Margrethe F.
    Sumner, Anne E.
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (03) : 135 - 137
  • [44] BUDGET IMPACT ANALYSIS OF VILDAGLIPTIN TREATING T2DM IN CHINA
    Fan, C. S.
    Guan, H. J.
    Wang, Y. N.
    VALUE IN HEALTH, 2016, 19 (03) : A200 - A200
  • [45] PROGRAM ACTIVE II: TREATING MAJOR DEPRESSION IN T2DM
    de Groot, Mary
    Hornsby, Guy
    Saha, Chandan K.
    Pillay, Yegan
    Fitzpatrick, Karen
    Mather, Kieren
    Shubrook, Jay
    ANNALS OF BEHAVIORAL MEDICINE, 2017, 51 : S1064 - S1065
  • [46] Pioglitazone safe and effective for treating T2DM in patients with NASH
    Tim Geach
    Nature Reviews Endocrinology, 2016, 12 (9) : 498 - 498
  • [47] Treating T2DM by ensuring insulin access is a global challenge
    Margrethe F. Horlyck-Romanovsky
    Anne E. Sumner
    Nature Reviews Endocrinology, 2019, 15 : 135 - 137
  • [48] Polymorphisms in GLP-1 receptor gene and susceptibility to type 2 diabetes mellitus (T2DM)
    Nagase, T
    Ji, LN
    Leech, C
    Pezolesi, M
    Habener, J
    Krolewski, A
    DIABETES, 2003, 52 : A254 - A254
  • [49] PSYCHOMETRIC EVALUATION OF THE NV QUESTIONNAIRE IN PATIENTS WITH T2DM RECEIVING A GLP-1 AGONIST
    McLeod, L.
    Sikirica, M., V
    Qin, S.
    Joshi, A., V
    Sweeney, C. T.
    Blum, S., I
    VALUE IN HEALTH, 2017, 20 (05) : A175 - A175
  • [50] Use of GLP-1 receptor agonists in patients with T2DM and chronic kidney disease
    Aldrich, Sarah
    Ashjian, Emily
    NURSE PRACTITIONER, 2019, 44 (03): : 20 - 28
12345